Condor Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Condor Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,476	Closed	-$3.56M	–	192
2024 Q3	$3.56M	Sell	24,476 -149	-0.6%	-$21.6K	0.32%	69
2024 Q2	$3.38M	Sell	24,625 -666	-3%	-$88.9K	0.32%	71
2024 Q1	$3.47M	Buy	+25,291	New	+$3.45M	0.34%	67
2022 Q1	–	Sell	-5,419	Closed	-$827K	–	458
2021 Q4	$827K	Buy	+5,419	New	+$839K	0.09%	140
2016 Q1	–	Sell	-2,187	Closed	-$247K	–	192
2015 Q4	$247K	Sell	2,187 -297	-12%	-$32.2K	0.06%	165
2015 Q3	$251K	Sell	2,484 -933	-27%	-$112K	0.07%	165
2015 Q2	$420K	Sell	3,417 -153	-4%	-$18.3K	0.1%	147
2015 Q1	$409K	Sell	3,570 -606	-15%	-$66.8K	0.1%	151
2014 Q4	$422K	Sell	4,176 -42	-1%	-$4.08K	0.11%	130
2014 Q3	$385K	Sell	4,218 -57	-1%	-$5K	0.11%	132
2014 Q2	$366K	Buy	+4,275	New	+$337K	0.1%	132
2013 Q4	–	Sell	-2,970	Closed	-$208K	–	160
2013 Q3	$208K	Buy	+2,970	New	+$195K	0.07%	148

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Condor Capital Management's IBB Position: Q4 2024 in Review

Condor Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 24,476 shares — an estimated $3.56M sold.

Condor Capital Management first reported a position in IBB in Q3 2013 and held it in 12 quarters. The position peaked at $3.56M in Q3 2024. 878 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Condor Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Condor Capital Management sold 24,476 iShares Biotechnology ETF shares in Q4 2024, an estimated $3.56M.
Condor Capital Management first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 12 quarters.
Condor Capital Management's iShares Biotechnology ETF position peaked at $3.56M in Q3 2024.
878 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Condor Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.